Expression of Pro-EPIL peptides encoded by the insulin-like 4 (INSL4) gene in chromosomally abnormal pregnancies

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 10, 2000, Pages 3941-3944

  Mock, Pascal ^a,b,d   Frydman, Rene ^a   Bellet, Dominique ^b,c   Chassin, Dorine ^e   Bischof, Paul ^d   Campana, Aldo ^d   Bidart, Jean Michel ^b,c  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; EARLY INSULIN LIKE PEPTIDE; GENE PRODUCT; INSULIN DERIVATIVE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

AMNION FLUID; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONE SYNTHESIS; HUMAN; MATERNAL SERUM; PREGNANCY DISORDER; PRIORITY JOURNAL; REGULATORY MECHANISM; TRISOMY 18; TRISOMY 21;

EID: 0033767696     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.10.6925     Document Type: Article

References (16)

1. Cloning a new member of the insulin gene superfamily (INSL4) expressed in human placenta
2. Insulin-like growth factors
3. Human relaxins: Chemistry and biology
4. Insulin-like 4 (INSL4) gene expression in human embryonic and trophoblastic tissues
5. Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta
6. Identification of INSL5, a new member of the insulin superfamily
7. Identification, chromosomal mapping, and partial characterization of mouse Ins16: A new member of the insulin family
8. Pro-EPIL forms are present in amniotic fluid and maternal serum during normal pregnancy
9. Sensitive and specific assay for human chorionic gonadotropin (hCG) based on anti-peptide and anti-hCG monoclonal antibodies; construction and clinical implications
10. Second-trimester maternal serum screening for Down's syndrome: Free β-human chorionic gonadotrophin (HCG) and alphafetoprotein, with or without unconjugated oestriol, compared with total HCG, alphafetoprotein and unconjugated oestriol
11. Screening of maternal serum for fetal down's syndrome in the first trimester
12. Pregnancy-associated plasma protein A levels in maternal serum, extraembryonic coelomic and amniotic fluids in the first trimester
13. Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies
14. Amniotic fluid levels of dimeric inhibins, pro-αC inhibin, activin A and follistatin in Down's syndrome
15. Functional regulation of human trophoblast differentiation